☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Exclusive Commercialization Agreement
Alvotech and Alvotech & CCHT Sign an Exclusive Commercialization Agreement with Yangtze River for Eight Biosimilars in China
November 25, 2020
Lotus Signs an Exclusive Commercialization Agreement with CKD for Biosimilar Darbepoetin Alfa
September 18, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
